Effect of drug-coated balloons in native coronary artery disease left with a dissection. J Am Coll Cardiol Intv. 2015

This important paper from our group was just published in JACC Interventions, and commented on TCTMD.

Please see comments here:

http://www.tctmd.com/show.aspx?id=133232&utm_source=2015-11-30-tctmd-newsletter&utm_medium=email&utm_campaign=tctmd-newsletter

@NEJM Ask the Authors & Experts: Everolimus-eluting Bioresorbable Scaffolds for Coronary Artery Disease & Bioresorbable Vascular Scaffolds–Will Promise Become Reality?

@NEJM Ask the Authors & Experts: Everolimus-eluting Bioresorbable Scaffolds for Coronary Artery Disease & Bioresorbable Vascular Scaffolds–Will Promise Become Reality?

Hello, today the New England Journal of Medicine Group Open Forum will begin. I have been invited to participate as an expert on Absorb BVS among a very high level panel (please see below).

I suggest you to click the link and follow this very important way to disseminate knowledge. 

DRUG-COATED-BALLOON GISE SYMPOSIUM

DRUG-COATED-BALLOON GISE SYMPOSIUM

Save the date!

During next meeting of GISE, the Italian Scientific Society of Interventional Cardiology, for the first time there will be a Symposium totally dedicated to drug-coated balloons.

Thanks to the efforts of the following companies: AB Medica, Biotronik, Hexacath and Movi, some of the most renown experts on the field will give a contemporary glimpse to this extraordinary technology.